Seres Therapeutics, Inc. (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Seres Therapeutics, Inc. (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Seres Therapeutics, Inc. (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Seres Therapeutics, Inc. (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
32 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Seres Therapeutics, Inc. (Seres), formerly Seres Health, Inc., is a microbiome therapeutics platform company that develops a novel class of biological drugs. It is involved in creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The companys lead development candidate, SER-109, is an oral microbiome therapeutic and bacterial spore ecology that is being developed for the prevention of recurrent Clostridium difficile infection in adults. Seres second development candidate, SER-287, is an oral therapy for the treatment of ulcerative colitis, an inflammatory bowel disease.

Seres Therapeutics, Inc. (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDPH503774D
Country
Industry
Ticker
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Seres Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Seres Therapeutics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Seres Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Seres Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Seres Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Seres Therapeutics, Inc., Pharmaceuticals &Healthcare, Deal Details1118
  Venture Financing111
    Seres Health Raises USD48 Million in Series C Venture Financing111
    Seres Health Raises USD10 Million in Series B Financing122
    Seres Health Raises US$10.5 Million In Series A Financing Round141
  Partnerships151
    Seres Therapeutics Enters into Agreement with Emulate151
    Seres Therapeutics Enters into Agreement with Massachusetts General Hospital161
    Seres Therapeutics Enters into Research Agreement with Mayo Clinic171
    Seres Therapeutics Enters into Research Agreement with Memorial Sloan Kettering Cancer Center181
    Seres Therapeutics Enters into Agreement with University of Pennsylvania191
    Seres Therapeutics Forms Partnership with Research Institute of St. Joseph s Hamilton201
    Seres Therapeutics Forms Partnership with Medical University of Graz211
    Seres Health Enters into Research Agreement with Mayo Clinic221
  Licensing Agreements231
    Nestle Health Science Enters into Licensing Agreement with Seres Therapeutics232
    Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research251
  Equity Offering261
    Seres Therapeutics Raises USD153.8 Million in IPO262
    Seres Health Raises USD65 Million in Financing281
Seres Therapeutics, Inc. - Key Competitors291
Key Employees301
Locations And Subsidiaries311
  Head Office311
Appendix321
  Methodology321
  About GlobalData321
  Contact Us321
  Disclaimer321

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Seres Therapeutics, Inc. (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Seres-Therapeutics-Inc-MCRB-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24981>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Seres Therapeutics, Inc. (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Seres-Therapeutics-Inc-MCRB-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24981>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research